Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E21.44 EPS (ttm)5.95 Insider Own0.02% Shs Outstand2.69B Perf Week0.44%
Market Cap343.46B Forward P/E16.62 EPS next Y7.67 Insider Trans-20.44% Shs Float2.69B Perf Month3.25%
Income16.51B PEG3.32 EPS next Q1.79 Inst Own68.30% Short Float0.53% Perf Quarter3.91%
Sales72.17B P/S4.76 EPS this Y8.30% Inst Trans0.24% Short Ratio2.36 Perf Half Y13.12%
Book/sh25.99 P/B4.91 EPS next Y8.00% ROA11.70% Target Price130.28 Perf Year12.51%
Cash/sh14.61 P/C8.73 EPS next 5Y6.45% ROE23.10% 52W Range109.32 - 129.00 Perf YTD10.69%
Dividend3.36 P/FCF40.10 EPS past 5Y11.20% ROI17.00% 52W High-1.61% Beta0.80
Dividend %2.63% Quick Ratio2.20 Sales past 5Y2.00% Gross Margin69.90% 52W Low16.10% ATR1.15
Employees126400 Current Ratio2.50 Sales Q/Q1.60% Oper. Margin27.80% RSI (14)60.78 Volatility0.76% 0.85%
OptionableYes Debt/Eq0.46 EPS Q/Q1.00% Profit Margin22.90% Rel Volume0.66 Prev Close127.53
ShortableYes LT Debt/Eq0.38 EarningsApr 18 BMO Payout52.80% Avg Volume6.09M Price126.92
Recom2.50 SMA201.43% SMA501.59% SMA2006.50% Volume4,002,172 Change-0.48%
May-18-17Reiterated Stifel Hold $124 → $128
May-15-17Upgrade JP Morgan Neutral → Overweight
Jan-26-17Downgrade Wells Fargo Outperform → Market Perform
Jan-25-17Reiterated RBC Capital Mkts Outperform $133 → $128
Oct-19-16Reiterated UBS Buy $137 → $144
Jul-21-16Reiterated Deutsche Bank Hold $125 → $142
Jul-20-16Reiterated UBS Buy $126 → $137
Jul-20-16Reiterated RBC Capital Mkts Outperform $125 → $133
May-20-16Initiated Standpoint Research Sell $94
Apr-20-16Reiterated RBC Capital Mkts Outperform $122 → $125
Apr-20-16Reiterated Piper Jaffray Neutral $105 → $106
Apr-15-16Reiterated RBC Capital Mkts Outperform $114 → $122
Mar-14-16Upgrade Goldman Sell → Neutral
Dec-01-15Upgrade Barclays Equal Weight → Overweight $101 → $115
Oct-05-15Resumed Piper Jaffray Neutral $105
May-21-15Reiterated Deutsche Bank Hold $106 → $110
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
May-26-17 03:41PM  Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data Motley Fool
12:08PM  3 Value Stocks for Every Investor Motley Fool
11:23AM  Johnson & Johnson : JNJ-US: Dividend Analysis : May 30th, 2017 (record date) : By the numbers : May 26, 2017 Capital Cube
May-25-17 03:56PM  Johnson & Johnson to Participate in the Goldman Sachs 38th Annual Global Healthcare Conference PR Newswire
02:36PM  Is Medical Technology Driving the US Healthcare Industry? Market Realist
08:50AM  Law: Mayor committed to assisted suicide law despite budget blocks American City Business Journals
07:55AM  Getting Struck Twice: Acquisitions And Spinouts In Biotech Forbes
07:36AM  Kyprolis Could Significantly Drive Amgens Revenue Growth in 2017 Market Realist
07:35AM  Mercks Immunology and Cardiovascular Franchise in 1Q17 Market Realist
May-24-17 06:10PM  Drugmaker paying $33M over recalled nonprescription meds Associated Press
02:35PM  Johnson & Johnson Settles U.S. Drug Manufacturing Probe TheStreet.com
01:33PM  J&J settles drug manufacturing probe by U.S. states for $33 mln Reuters
12:30PM  J&J settles drug manufacturing probe by U.S. states for $33 million Reuters
10:37AM  Neupogen and Enbrel Could See Falling Revenues in 2017 Market Realist
09:25AM  What Do AA+ And AAA Credit Ratings Mean? Investopedia
08:15AM  This Dividend Aristocrat is Going to Trade Ex-Dividend on May 25 Accesswire
08:04AM  Intuitive Surgical Stock Just Hit an All-Time High: Buy, Sell, or Hold? Motley Fool
May-23-17 05:42PM  3 Top Dividend Stocks in the Dentistry Industry Motley Fool
12:42PM  Alexions top management shake-up includes CFO who started in December MarketWatch
12:18PM  Here's Why Alexion Pharma (ALXN) Stock is Sinking Today Zacks
12:01PM  Alexion stock plummets 9% after top management shake-up MarketWatch
11:05AM  Analysts Expect Medtronics Revenue to Rise 4% in Fiscal 4Q17 Market Realist
09:41AM  3 Stocks to Add to Your Social Security Income Motley Fool
May-22-17 08:42AM  The 3 Best Dividend Stocks in Arthritis Medication Motley Fool
08:07AM  These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop? Motley Fool
May-21-17 07:41AM  3 Ways Johnson & Johnson's Pharmaceutical Business Plans to Beat the Market Motley Fool
May-20-17 10:41AM  5 Entrepreneur Ideas From Tremendously Innovative Companies Motley Fool
May-19-17 03:17PM  Dow 30 Stock Roundup: Home Depot, Cisco, Wal-Mart Beat on Earnings Zacks
10:12AM  Johnson & Johnson Unit Sues to Block Sale of Copy of its Rheumatoid Arthritis Drug TheStreet.com
07:47AM  Why Is Johnson & Johnson (JNJ) Up 4.4% Since the Last Earnings Report? Zacks
May-18-17 11:51PM  Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy Reuters
11:42PM  Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy Reuters
07:08PM  Ortho-Clinical Diagnostics SA -- Moody's assigns B1 to Ortho-Clinical's proposed senior secured revolving credit facility Moody's
02:26PM  Why Achillion Pharmaceuticals Stock Is Jumping 15% Today Motley Fool
02:02PM  Why ImmunoGen, Inc. Jumped Higher Today Motley Fool
01:57PM  Understanding J&J's Risk From New FDA Label Warning For Invokana Forbes
12:39PM  3 Warren Buffett Stocks for Senior Citizens Motley Fool
12:10PM  Achillion: It Can't Get Any WorseOr Can It? Barrons.com
10:23AM  J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021 Zacks
07:37AM  Inside Bristol-Myers Squibbs Valuation after the 1Q17 Earnings Market Realist
06:08AM  Johnson & Johnson offers EU concessions over Actelion deal Reuters
May-17-17 03:28PM  Shares of Colgate-Palmolive (CL) Pop as CEO May Want to Sell Zacks
02:11PM  Johnson & Johnson analysts' day CNBC Videos
01:46PM  Johnson & Johnson Execs Discuss Drug Pipeline TheStreet.com
12:59PM  Is Colgate Ready for a 3G Cleaning? Bloomberg
12:54PM  [$$] Johnson & Johnson Faces FDA Headwind Barrons.com
10:06AM  The world's largest drugmaker thinks it has 11 billion-dollar drugs in the pipeline here's what they treat Business Insider
09:00AM  J&J's target: Launch or seek approval for 10 new medicines by 2021 American City Business Journals
08:20AM  3 Dividend Stocks That Laugh at Market Crashes Motley Fool
07:20AM  J&J CEO: We have to pay attention to out-of-pocket drug c... CNBC Videos
07:07AM  Johnson & Johnson plans to file for approval 10 potential blockbusters in next 4 years MarketWatch
06:45AM  J&J plans to seek approval of more than 10 new medicines ... CNBC Videos
06:44AM  Johnson & Johnson Showcases Strong Pipeline of Transformational Medicines at its Pharmaceutical Business Review Meeting PR Newswire
May-16-17 06:14PM  U.S. FDA warns of foot, leg amputations with J&J diabetes drug Reuters
04:40PM  Lilly Could Grab Diabetes Share From Dow's J&J On Amputation Woes Investor's Business Daily
02:20PM  3 Large-Cap Stocks for Your Retirement Motley Fool
08:08AM  Johnson & Johnson breached its 50 day moving average in a Bullish Manner : JNJ-US : May 16, 2017 Capital Cube
May-15-17 08:59PM  New York county sues Purdue, J&J over opioid marketing Reuters
05:46PM  New York county sues Purdue, J&J over opioid marketing Reuters
05:36PM  New York county sues Purdue, J&J over opioid marketing Reuters
04:28PM  S&P 500, Nasdaq close at records as oil rallies to 2-week high MarketWatch
04:24PM  Stocks Rumble To A Bullish Close; IBD 50 Names Outperform Investor's Business Daily
04:21PM  Cisco, J&J, Starbucks Upgraded, Tesla Downgraded Investopedia
04:01PM  Tesla Downgraded; Starbucks, Cisco, Johnson & Johnson Upgraded Investor's Business Daily
03:12PM  Dow's late-session gain driven by J&J, Caterpillar, Goldman stock MarketWatch
02:23PM  Watch Johnson & Johnson Break Record Highs TheStreet.com
11:56AM  3 Health Care Stocks to Own for 2017 TheStreet.com
11:54AM  Johnson & Johnson leads the Dow higher after JPMorgan upgrades stock CNBC
11:29AM  Johnson & Johnson's stock jumps after analyst turns bullish for first time in 4 years MarketWatch
11:10AM  Johnson & Johnson's Sales Slump Has Played Itself Out, Could Reaccelerate This Year Benzinga
11:05AM  Johnson & Johnson: Trouble Behind? Barrons.com
10:30AM  AbbVie and J&J Present Positive Imbruvica Leukemia Data Zacks
09:15AM  Johnson & Johnson Stock Rises on JPMorgan Upgrade TheStreet.com
08:56AM  Analysts' Actions -- Cisco, J.C. Penney, Johnson & Johnson, Tesla and More TheStreet.com
08:06AM  Israel's BiomX raises $24 mln in private funding round Reuters
07:45AM  Early movers: SYMC, PANW, FEYE, PTHN, TMO, MCO, JNJ, BWLD & more CNBC
May-12-17 05:00PM  Johnson & Johnson Analyst Day Yahoo Finance Video
09:30AM  The Zacks Analyst Blog Highlights: O'Shares FTSE U.S. Quality Dividend ETF, Apple, Johnson & Johnson and Exxon Mobil Zacks
May-11-17 02:45PM  Johnson & Johnson settles Oregon suit over Motrin buyback Associated Press
02:16PM  Johnson & Johnson to Participate in the Jefferies 2017 Global Healthcare Conference PR Newswire
12:14PM  Why MBA programs' entrepreneurial training might not serve companies looking to hire those grads American City Business Journals
May-10-17 12:28PM  Better Buy: GlaxoSmithKline vs. Johnson & Johnson Motley Fool
08:15AM  Geron (GERN) Q1 Loss In Line, Focus Remains on Imetelstat Zacks
May-09-17 04:50PM  Low volatility means historic opportunities to buy options, Goldman says MarketWatch
03:57PM  J&J discloses U.S. government probes Reuters Videos
03:25PM  Losing Sleep Over Your Portfolio? Consider These Stocks Motley Fool
10:29AM  Sanofi pegs U.S. drug price rises to below healthcare inflation Reuters
09:06AM  Comparing Pfizers Valuation to Peers after 1Q17 Earnings Market Realist
08:06AM  1 Chart That Shows How Badly Dividend Aristocrats Have Kicked the S&P 500's Butt Since 1991 Motley Fool
08:02AM  Early movers: VRX, AGN, W, ODP, PRTY, VZ, WFC, UAL, P & more CNBC
May-08-17 06:49PM  J&J discloses U.S. probe related to arthritis drugs Reuters
05:24PM  4 Drug Stocks Poised to Beat this Earnings Season Zacks
02:01PM  Achillion (ACHN) Reports Wider-than-Expected Loss in Q1 Zacks
11:29AM  More Trouble Ahead For Valeant? Barrons.com
09:35AM  St. Louis jury orders Johnson & Johnson to pay $110 million in latest talc case American City Business Journals
09:34AM  J&J: What's In Store At Next Week's Analyst Meeting Barrons.com
08:46AM  Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit Zacks
07:37AM  These 3 Stocks Just Raised Their Dividends Motley Fool
May-07-17 01:00PM  Google's YouTube to Offer New Shows With Ellen DeGeneres, Kevin Hart to Attract Premium Ad Dollars TheStreet.com
07:22AM  Better Buy: Amgen Inc. vs. Johnson & Johnson Motley Fool
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising brand adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duato JoaquinExec VP, WW Chair, PharmaMar 03Option Exercise59.7650,0002,987,780118,536Mar 07 04:21 PM
Duato JoaquinExec VP, WW Chair, PharmaMar 03Sale123.6250,0006,181,14068,536Mar 07 04:21 PM
Kapusta Ronald AController, CAOFeb 28Option Exercise72.5414,5431,054,94944,507Mar 02 05:50 PM
Kapusta Ronald AController, CAOFeb 28Sale122.2614,5431,777,95429,964Mar 02 05:50 PM
Pruden Gary JExec VP, WW Chair, Med DevicesFeb 28Sale122.2116,2991,991,94343,630Mar 02 05:16 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale117.2922,0002,580,274127,650Feb 16 06:53 PM
Caruso Dominic JExec VP, Finance; CFOFeb 13Option Exercise0.0026,9470150,700Feb 15 10:00 PM
Kapusta Ronald AController, CAOFeb 13Option Exercise0.002,148030,052Feb 16 06:01 AM
Pruden Gary JExec VP, WW Chair, Med DevicesFeb 13Option Exercise0.0015,532063,405Feb 16 06:01 AM
Duato JoaquinExec VP, WW Chair, PharmaFeb 13Option Exercise0.0022,298075,814Feb 16 06:01 AM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0015,598068,899Feb 16 06:01 AM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.0084,2990280,617Feb 16 06:01 AM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 13Option Exercise0.0027,667069,436Feb 16 06:01 AM
Stoffels PaulusExec VP, Chief Scientific OffFeb 13Option Exercise0.0026,4470156,125Feb 16 06:01 AM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0014,6000114,866Feb 16 06:01 AM
Ullmann Michael HExec VP, General CounselFeb 01Option Exercise65.6227,7351,819,971119,190Feb 03 12:05 PM
Ullmann Michael HExec VP, General CounselFeb 01Sale112.8821,7352,453,44297,455Feb 03 12:05 PM
PRINCE CHARLESDirectorOct 21Buy114.1187599,84626,520Oct 25 01:52 PM
JOHNSON & JOHNSON10% OwnerAug 16Buy12.00583,3336,999,9962,449,183Aug 18 05:11 PM
Caruso Dominic JExec VP, Finance; CFOJul 26Option Exercise65.6241,1462,700,001157,819Jul 28 04:34 PM
Caruso Dominic JExec VP, Finance; CFOJul 26Sale125.0141,1465,143,810116,673Jul 28 04:34 PM
Kapusta Ronald AController, CAOJul 22Sale125.012,935366,89625,725Jul 25 03:18 PM
Kapusta Ronald AController, CAOJul 21Option Exercise58.332,935171,19928,660Jul 25 03:18 PM
Kapusta Ronald AController, CAOJun 07Option Exercise58.333,000174,99028,725Jun 09 04:11 PM
Pruden Gary JExec VP, WW Chair, Med DevicesJun 07Sale116.039,7351,129,55243,630Jun 09 04:12 PM
Kapusta Ronald AController, CAOJun 07Sale115.793,000347,38125,725Jun 09 04:11 PM